← Back to Clinical Trials
Recruiting NCT07017413

NCT07017413 Predictors For Transosseous Maxillary Sinus Lift Complications

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07017413
Status Recruiting
Phase
Sponsor University of Baghdad
Condition Sinus Lift Surgery Complications
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-11-30
Primary Completion 2025-10-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Transosseous Maxillary Sinus Lift using Osseodensification

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-11-30 with a primary completion date of 2025-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective cohort study aims to identify clinical and anatomical predictors for complications following transosseous maxillary sinus lift procedures using the Versah (Densah burs) technique. The study focuses on patients undergoing transcrestal sinus floor elevation without a lateral window, with or without simultaneous dental implant placement. Variables such as residual bone height, sinus membrane thickness, bone density, and patient-related factors are being evaluated. The objective is to enhance risk stratification and optimize treatment planning for transosseous sinus augmentation.

Eligibility Criteria

Inclusion Criteria: * 1- Patients requiring dental implants in the posterior maxilla with a residual bone height of \< 6 mm. 2- Good general health and absence of systemic conditions affecting bone healing (e.g., uncontrolled diabetes, osteoporosis). 3- No history of chronic sinusitis or other significant sinus pathologies Exclusion Criteria: * 1- Severe periodontal disease. 2- Residual bone height \> 6 mm. 3- History of previous sinus lift procedures or other maxillofacial surgeries. 4- Smokers.

Contact & Investigator

Central Contact

Mustafa Al-Jamal, BDS, MSc, PhD

✉ dr.mustafa.faisal9@gmail.com

📞 +9647704681045

Frequently Asked Questions

Who can join the NCT07017413 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Sinus Lift Surgery Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07017413 currently recruiting?

Yes, NCT07017413 is actively recruiting participants. Contact the research team at dr.mustafa.faisal9@gmail.com for enrollment information.

Where is the NCT07017413 trial being conducted?

This trial is being conducted at Baghdad, Iraq, Baghdad, Iraq.

Who is sponsoring the NCT07017413 clinical trial?

NCT07017413 is sponsored by University of Baghdad. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology